Asia Pacific pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 375.42 million by 2029, at a CAGR of 10.6% during the forecast period. Anxiety accounts for the largest type segment in the market due to the increasing depression rate among the Asia Pacific population.
Not to mention, large sample sizes have been exploited for the collection of data...